CAS: 30359-01-4 - (-)-Centrolobol
Fórmula:C19H24O3
InChI:InChI=1S/C19H24O3/c20-17(10-7-16-8-13-19(22)14-9-16)4-2-1-3-15-5-11-18(21)12-6-15/h5-6,8-9,11-14,17,20-22H,1-4,7,10H2/t17-/m1/s1
Clave InChI:InChIKey=UYJAYWZGEZOHRU-QGZVFWFLSA-N
SMILES:OC1=CC=C(C=C1)CCCCC(O)CCC2=CC=C(O)C=C2
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Centrolobol REF: TM-TN3621CAS: 30359-01-4 | 98% | A consultar | Jue 09 May 24 |
 | Centrolobol REF: BP-SBP01879CAS: 30359-01-4 | 95%~99% | A consultar | Lun 13 May 24 |
 | Centrolobol REF: 4Z-P-5786CAS: 30359-01-4 | - - - | A consultar | Mié 15 May 24 |
 | Centrolobol REF: 3D-FBA35901CAS: 30359-01-4 | Min. 95% | A consultar | Jue 20 Jun 24 |
Centrolobol
CAS:30359-01-4
(-)-Centrolobol has antifibrotic activity, it can significantly inhibit the proliferation of HSC-T6 cells in a …
Fórmula:
C19H24O3
Pureza:
98%
Forma y color:
Solid
Peso molecular:
300.39
Ref: TM-TN3621
| 1mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 9 de Mayo de 2024
Ref: BP-SBP01879
| Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Lunes 13 de Mayo de 2024
Ref: 4Z-P-5786
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Miércoles 15 de Mayo de 2024
Centrolobol
CAS:30359-01-4
Centrolobol is a pharmaceutical preparation that inhibits histone deacetylase activity. It has been shown to …
Fórmula:
C19H24O3
Pureza:
Min. 95%
Peso molecular:
300.4 g/mol
Ref: 3D-FBA35901
| 1mg | A consultar | |
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 20 de Junio de 2024
